InvestorsHub Logo
Followers 21
Posts 2057
Boards Moderated 0
Alias Born 06/14/2007

Re: DewDiligence post# 11272

Tuesday, 03/04/2014 9:41:59 AM

Tuesday, March 04, 2014 9:41:59 AM

Post# of 20689
Yeah that didn't seem out of the ordinary. He still emphasized that the FDA is focusing on the patent expiration dates for approval priority. I think the issue is the new way the FDA communicates.

On another note, if MNTA gets another small CRL for their application, would that have to be PR'd since it is essentially so close to the patent expiration?